Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases
Abstract Objective This study is to review published cases of peripartum cardiomyopathy (PPCM) treated with bromocriptine and outline pros and cons of the treatment strategy. Data Sources Data were collected from PubMed/MedLine, ClinicalTrials.gov; the years 2007 to 2018 we...
Main Authors: | Rebecca Simon, Sophia Yang, Afshan B. Hameed |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical Publishers, Inc.
2018-10-01
|
Series: | American Journal of Perinatology Reports |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1675832 |
Similar Items
-
Bromocriptine use for sudden peripartum cardiomyopathy in a patient with preeclampsia: a case report
by: Saya Hakata, et al.
Published: (2019-06-01) -
Bromocriptine as a new therapeutic agent for peripartum cardiomyopathy
by: Sandeep Chopra, et al.
Published: (2012-01-01) -
Peripartum Cardiomyopathy
by: Riccardo Raddino, et al.
Published: (2016-01-01) -
One year survival in Nigerians with peripartum cardiomyopathy
by: Kamilu M Karaye, et al.
Published: (2016-01-01) -
Peripartum Cardiomyopathy Presenting With Ventricular Tachycardia: A Rare Presentation
by: A Puri, et al.
Published: (2009-05-01)